Skip to main content
Fig. 1 | Clinical and Molecular Allergy

Fig. 1

From: Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy

Fig. 1

Schematic overviews of the experimental set-ups. Treatment protocol 1 Safety To study the ability of scFOS/lcFOS to improve the safety of SCIT in PE sensitized mice. Treatment protocol 2 Efficacy To study the ability of scFOS/lcFOS to improve the efficacy of SCIT in PE sensitized mice. PE, peanut extract; CT, cholera toxin; SCIT, subcutaneous immunotherapy; s.c., subcutaneous; i.d., intradermal; i.g., intragastric; i.p., intraperitoneal

Back to article page

Clinical and Molecular Allergy

ISSN: 1476-7961

Contact us